All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11130%2F17%3A10373651" target="_blank" >RIV/00216208:11130/17:10373651 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064203:_____/17:10373651

  • Result on the web

    <a href="https://doi.org/10.1182/bloodadvances.2017006734" target="_blank" >https://doi.org/10.1182/bloodadvances.2017006734</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1182/bloodadvances.2017006734" target="_blank" >10.1182/bloodadvances.2017006734</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Intragenic amplification of PAX5: a novel subgroup in B-cell precursor acute lymphoblastic leukemia?

  • Original language description

    B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most common childhood malignancy, characterized by a wide spectrum of genetic abnormalities, which are used in risk stratification for treatment. PAX5 encodes a transcription factor, which plays a key role in B-cell commitment and maintenance and is frequently (20% to 35%) deleted or mutated in BCP-ALL. Germline PAX5 mutations also occur in familial ALL. Furthermore, chromosomal rearrangements involving PAX5 result in the expression of potentially oncogenic PAX5 fusion genes. Here we present a subset of patients with BCP-ALL lacking the major cytogenetic abnormalities (ETV6-RUNX1, BCR-ABL1, and TCF3-PBX1 fusions, high hyperdiploidy, near-haploidy, low hypodiploidy, MLL rearrangements, or intrachromosomal amplification of chromosome 21) with intragenic amplifications of PAX5 (PAX5AMP).

  • Czech name

  • Czech description

Classification

  • Type

    O - Miscellaneous

  • CEP classification

  • OECD FORD branch

    30204 - Oncology

Result continuities

  • Project

    <a href="/en/project/NV15-30626A" target="_blank" >NV15-30626A: High-throughput genomic profiling for personalised diagnostics and treatment of haematopoietic disorders in children</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů